Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Controlled Trial on the Efficacy of 20% Human Albumin in Reducing Pleural Effusion After Cardiopulmonary Bypass

NCT06681415 is registered in ClinicalTrials.gov with Pauls Stradins Clinical University Hospital as lead sponsor.

NCT NCT06681415
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06681415 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Controlled Trial on the Efficacy of 20% Human Albumin in Reducing Pleural Effusion After Cardiopulmonary Bypass
Lead sponsor
Pauls Stradins Clinical University Hospital
Phase
Phase 4
Overall status
Completed
Start date
September 1, 2022
Completion date
January 1, 2024
Enrollment
70 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hypoalbuminemia, hypoxia, pleural effusions post coronary artery bypass graft